- IPA’s Subsidiary, BioStrand, Announces Advanced Large Language Model (LLM) for Electronic Health Records (EHR)
- InterSystems and IPA’s Subsidiary BioStrand Collaborate to Unveil the Innovative Integration of Vector Search with LENSai for AI-Driven Healthcare Applications
- IPA Acquires the Carterra LSA® Instrument to Enhance Antibody Discovery and Bolster Its AI Developments
- IPA Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2024*
Key statistics
On Friday, Immunoprecise Antibodies Ltd (IPA:NMQ) closed at 0.99, 5.32% above its 52-week low of 0.94, set on Dec 06, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.9875 |
---|---|
High | 1.00 |
Low | 0.96 |
Bid | 1.00 |
Offer | 1.03 |
Previous close | 0.99 |
Average volume | 76.14k |
---|---|
Shares outstanding | 26.32m |
Free float | 22.74m |
P/E (TTM) | -- |
Market cap | 26.58m USD |
EPS (TTM) | -0.4134 USD |
Data delayed at least 15 minutes, as of Jun 07 2024 20:59 BST.
More ▼